Cytosorbents (CTSO) EPS (Diluted) Growth (1y) (2015 - 2026)
Powered by 
Analysis
Cytosorbents (CTSO) EPS (Diluted) Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -47.60% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 26.30% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 41.58% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 44.49% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 15.24% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -25.88% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 44.97% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.96% |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | -342.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -342.61% |
| Mar 31, 2026 | -235.70% |
| Dec 31, 2025 | 36.46% |
| Sep 30, 2025 | 0.63% |
| Jun 30, 2025 | 136.66% |
| Mar 31, 2025 | 79.22% |
| Dec 31, 2024 | -6.39% |
| Sep 30, 2024 | 75.46% |
| Jun 30, 2024 | 43.44% |
| Mar 31, 2024 | 30.15% |
| Dec 31, 2023 | -643.14% |
| Sep 30, 2023 | 25.95% |
| Jun 30, 2023 | 44.03% |
| Mar 31, 2023 | 22.19% |
| Dec 31, 2022 | 91.81% |
| Sep 30, 2022 | -89.53% |
| Jun 30, 2022 | -131.29% |
| Mar 31, 2022 | -124.06% |
| Dec 31, 2021 | -1,129.48% |
| Sep 30, 2021 | -631.20% |